Adherence and Reactogenicity to Vaccines against SARS-COV-2 in 285 Patients with Neuropathy: A Multicentric Study

Background: The safety of the new vaccines against SARS-CoV-2 have already been shown, although data on patients with polyneuropathy are still lacking. The aim of this study is to evaluate the adherence to SARS-CoV-2 vaccination, as well as the reactogenicity to those vaccines in patients affected b...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Salvatore Iacono, Vincenzo Di Stefano, Paolo Alonge, Claudia Vinciguerra, Giammarco Milella, Francesca Caputo, Piergiorgio Lasorella, Gabriele Neto, Antonia Pignolo, Angelo Torrente, Antonino Lupica, Paola Ajdinaj, Alberto Firenze, Stefano Tozza, Fiore Manganelli, Antonio Di Muzio, Giuseppe Piscosquito, Filippo Brighina
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-10-01
coleção:	Brain Sciences
Assuntos:	SARS-CoV-2 infection COVID-19 vaccines reactogenicity vaccine safety vaccine hesitancy neuropathy
Acesso em linha:	https://www.mdpi.com/2076-3425/12/10/1396
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!